Analysis of the cytokine profile in spleen cells from dogs naturally infected by Leishmania chagasi

Veterinary Immunology and Immunopathology

Volumn 115, Issue 1-2, 2007, Pages 135-145

  Lage, R S ^a   Oliveira, G C ^a,b,c   Busek, S U ^a   Guerra, L L ^a   Giunchetti, R C ^a,b   Correa Oliveira R ^a   Reis, A B ^a,b  

^a INSTITUTO OSWALDO CRUZ   (Brazil)

^b FEDERAL UNIVERSITY OF OURO PRETO   (Brazil)

^c Programa de Pos Graduacao e Pesquisa   (Brazil)

Author keywords

Canine diseases; Cytokines; Leishmania chagasi; RT PCR; Visceral leishmaniasis

Indexed keywords

CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 4; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BIOACCUMULATION; COMPARATIVE STUDY; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOKINE PRODUCTION; DISEASE COURSE; DOG; DOG DISEASE; IMMUNOASSAY; LEISHMANIA CHAGASI; NONHUMAN; PARASITE VIRULENCE; PARASITISM; PROTEIN EXPRESSION; QUANTITATIVE ASSAY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SPLEEN CELL; STANDARDIZATION; TH1 CELL; TH2 CELL; VISCERAL LEISHMANIASIS;

ANIMALS; CYTOKINES; DOG DISEASES; DOGS; LEISHMANIA INFANTUM; LEISHMANIASIS, VISCERAL; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SPLEEN;

ANIMALIA; CANIS FAMILIARIS; LEISHMANIA DONOVANI CHAGASI;

EID: 33845485491     PISSN: 01652427     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vetimm.2006.10.001     Document Type: Article

References (49)

1. Acedo-Sanchez C., Morillas-Marquez F., Sanchiz-Marin M.C., and Martin-Sanchez J. Changes in antibody titres against Leishmania infantum in naturally infected dogs in southern Spain. Vet. Parasitol. 75 (1998) 1-8
2. Awasthi A., Mathur R.K., and Saha B. Immune response to Leishmania infection. Indian J. Med. Res. 119 (2004) 238-258
3. Bacellar O., Brodskyn C., Guerreiro J., Barral-Neto M., Costa C.H., Coffman R.L., Jonson W.D., and Carvalho E.M. Interleukin-12 restores interferon-g production and cytotoxic responses in visceral leishmaniasis. J. Infect. Dis. 173 (1996) 1515-1518
4. Baneth G., and Shaw S.E. Chemotherapy of canine leishmanioses. Vet. Parasitol. 106 (2002) 315-324
5. Barral A., Barral-Neto M., Yong E.C., Brownell C.E., Twardzik D.R., and Reed S.G. Transforming growth factor-β as a virulencemechanism for Leishmania braziliensis. Proc. Natl. Acad. Sci. U.S.A. 90 (1993) 3442-3446
6. Barral-Neto M., Brodskyn C., Carvalho E.M., and Barral A. Braz. J. Med. Biol. Res. 31 (1998) 149-155. Human_Leishmaniasis@cytokines.bahia.br
7. Belkaid Y., Hoffmann K.F., Mendez S., Kamhawi S., Udey M.C., Wynn T.A., and Sacks D.L. The role of interleukin (IL)-10 in the persistence of Leishmania major in the skin after healing and the therapeutic potential of anit-IL-10 receptor antibody for sterile cure. J. Exp. Med. 194 (2001) 1497-1506
8. Boehler A. The role of interleukin-10 in lung transplantation. Transpl. Immunol. 9 (2002) 121-124
9. Bogdan C., Vodovotz Y., and Nathan C. Macrophage deactivation by interleukin 10. J. Exp. Med. 174 (1991) 1549-1555
10. Cabral M., O'Grady J., and Alexander J. Demonstration of Leishmania specific cell mediated and humoral immunity in asymptomatic dogs. Parasite Immunol. 14 (1992) 531-539
11. Campino L., and Abranches P. Cutaneous leishmaniasis. Unusual disease in Portugal?. Acta Med. Port. 15 (2002) 387-390
12. Chamizo C., Rubio J.M., Moreno J., and Alvar J. Semi-quantitative analysis of multiple cytokines in canine peripheral blood mononuclear cells by a single tube RT-PCR. Vet. Immunol. Immunopathol. 83 (2001) 191-220
13. Chamizo C., Moreno J., and Alvar J. Semi-quantitative analysis of cytokine expression in asymptomatic canine leishmaniasis. Vet. Immunol. Immunopathol. 103 (2005) 67-75
14. Cobbold S., and Metcalfe S. Monoclonal antibodies that define canine homologues of human CD antigens: summary of the 1st International Canine Leukocyte Antigen Workshop (CLAW). Tissue Antigens 43 (1994) 137-154
15. De Luna R., Vuotto M.L., Ielpo M.T., Ambrosio R., Piantedosi D., Moscatiello V., Ciaramella P., Scalone A., Gradoni L., and Mancino D. Early suppression of lymphoproliferative response in dogs with natural infection by Leishmania infantum. Vet. Immunol. Immunopathol. 70 (1999) 95-103
16. Desjeux P. Worldwide increasing risk factors for leishmaniasis. Med. Microbiol. Immunol. (Berl) 190 (2001) 77-79
17. Desjeux P. Leishmaniasis: current situation and new perspectives. Comp. Immunol. Microbiol. Infect. Dis. 27 (2004) 305-318
18. El Amin E.M., Wright E.P., and Vlug A. Characterization of the humoral immune response in Sudanese leishmaniasis: specific antibody detected by class- and subclass-specific reagents. Clin. Exp. Immunol. 64 (1986) 14-19
19. Engwerda C.R., Smelt S.C., and Kaye P.M. An in vivo analysis of cytokine production during Leishmania donovani infection in scid mice. Exp. Parasitol. 84 (1996) 195-202
20. Fisa R., Gallego M., Castillejo S., Aisa M.J., Serra T., Riera C., Carrio J., Gallego J., and Portus M. Epidemiology of canine leishmaniosis in Catalonia (Spain) the example of the Priorat focus. Vet. Parasitol. 83 (1999) 87-97
21. Giunchetti R.C., Mayrink W., Genaro O., Carneiro C.M., Corrêa-Oliveira R., Martins-Filho O.A., Marques M.J., Tafuri W.L., and Reis A.B. Relationship between canine visceral leishmaniosis and the Leishmania (Leishmania) chagasi burden in dermal inflammatory foci. J. Comp. Path. 135 (2006) 100-107
22. Ghalib H.W., Piuvezam M.R., Sheiky Y., Siddig M., Hashim F.A., El Hassam A.M., Russo D.M., and Reed S.G. Interleukin-10 production correlates with pathology in human Leishmania donovani infections. J. Clin. Invest. 92 (1993) 324-329
23. + cell populations in vivo and ameliorates Th1 diabetes in non-obese diabetic mice in a dose-dependent fashion. J. Immunol. 171 (2003) 2270-2278
24. Gröne A., Frisk A.L., and Baumgartner W. Cytokine mRNA expression in whole blood samples from dogs with natural canine distemper virus infection. Vet. Immunol. Immunopathol. 65 (1998) 11-27
25. Kane M.M., and Mosser D.M. The role of interleukin-10 in promoting disease progression in leishmaniasis. J. Immunol. 166 (2001) 1141-1147
26. Karp C.L., El Safi S.H., Wynn T., Satti M.M., Kordafoni A.M., Hashim F.A., Hag-Ali M., Neva F.A., Nutman T.B., and Sacks D.L. In vivo cytokine profiles in patients with Kala-azar. J. Clin. Invest. 91 (1993) 1644-1648
27. Kemp K., Kemp M., Kharazmi A., Ismail A., Kurtzhals J.A., Hviid L., and Theander T.G. Leishmania-specific T cells expressing interferon-gamma (IFN-gamma) and IL-10 upon activation are expanded in individuals cured of visceral leishmaniasis. Clin. Exp. Immunol. 116 (1999) 500-504
28. Kenney R.T., Sacks D.L., Gam A.A., Murray H.W., and Sundar S. Splenic cytokine responses in Indian Kala-azar before and after treatment. J. Infect. Dis. 177 (1998) 815-818
29. Mancianti F., Gramiccia M., Gradoni L., and Pieri S. Studies on canine leishmaniais control. I. Evolution of infection of different clinical forms of canine leishmaniasis following antimonsyl treatment. Roy. Soc. Trop. Med. Hyg. 82 (1988) 566-567
30. Martinez-Moreno A., Moreno T., Martinez-Moreno F.J., Acosta I., and Hernandez S. Humoral and cell-mediated immunity in natural and experimental canine leishmaniasis. Vet. Immunol. Immunopathol. 48 (1995) 209-220
31. Melby P.C., Tryon V.V., Chandrasekar B., and Freeman G.L. Cloning of Syrian hamster (Mesocricetus auratus) cytokine cDNAs and analysis of cytokine mRNA expression in experimental visceral leishmaniasis. Infect. Immun. 66 (1998) 2135-2142
32. Molina R., Amela C., Nieto J., San-Andres M., Gonzalez F., Castillo J.A., Lucientes J., and Alvar J. Infectivity of dogs naturally infected with Leishmania infantum to colonized Phlebotomus perniciosus. Trans. Roy. Soc. Trop. Med. Hyg. 88 (1994) 491-493
33. Moreno J., and Alvar J. Canine leishmaniasis: epidemiological risk and the experimental model. Trends Parasitol. 18 (2002) 399-405
34. Moreno J., Nieto J., Chamizo C., Gonzalez F., Blanco F., Barrer D.C., and Alvar J. The immune response and PBMC subsets in canine visceral leishmaniasis before, and after, chemotherapy. Vet. Immunol. Immnopathol. 71 (1999) 181-195
35. Mosmann T.R., and Moore K.W. The role of IL-10 in cross regulation of TH1 and TH2 responses. Immunol. Today 12 (1991) A49-A53
36. Pinelli E., Killick-Kendrick R., Wagenaar J., Bernadina W., Del Real G., and Ruitenberg J. Cellular and humoral immune responses in dogs experimentally and naturally infected with Leishmania infantum. Infect. Immun. 62 (1994) 229-235
37. Pinelli E., Van Der Kaaij S.Y., Slappendel R., Fragio C., Ruitenberg E.J., Bernadina W., and Rutten V.P. Detection of canine cytokine gene expression by reverse transcription-polymerase chain reaction. Vet. Immunol. Immunopathol. 69 (1999) 121-126
38. Quinnell R.J., Courtenay O., Shaw M.A., Day M.J., Garcez L.M., Dye C., and Kaye P.M. Tissue cytokine responses in canine visceral leishmaniasis. J. Infect. Dis. 183 (2001) 1421-1424
39. Reed S.G., Brownell C.E., Russo D.M., Silva J.S., Grabstein K.H., and Morrissey P.J. IL-10 mediates susceptibility to Trypanosoma cruzi infection. J. Immunol. 1535 (1994) 3135-3140
40. Reis A.B., Martins-Filho O.A., Teixeira-Carvalho A., Carvalho M.G., Mayrink W., Franca-Silva J.C., Giunchetti R.C., Genaro O., and Correa-Oliveira R. Parasite density and impaired biochemical/hematological status are associated with severe clinical aspects of canine visceral leishmaniasis. Res. Vet. Sci. 81 (2006) 68-75
41. Reis A.B., Teixeira-Carvalho A., Vale A.M., Marques M.J., Giunchetti R.C., Mayrink W., Guerra L.L., Andrade R.A., Correa-Oliveira R., and Martins-Filho O.A. Isotype patterns of immunoglobulins: hallmarks for clinical status and tissue parasite density in Brazilian dogs naturally infected by Leishmania (Leishmania) chagasi. Vet. Immunol. Immunopathol. 112 (2006) 102-116
42. Reis A.B., Teixeira-Carvalho A., Giunchetti R.C., Guerra L.L., Carvalho M.G., Mayrink W., Genaro O., Corrêa-Oliveira R., and Martins-Filho O.A. Phenotypic features of circulating leucocytes as immunological markers for clinical status and bone marrow parasite density in dogs naturally infected by Leishmania chagasi. Clin. Exp. Immunol. 146 (2006) 303-311
43. Richard T.K., David L.S., Albert A.G., Henry W.M., and Shyam S. Splenic cytokine responses in Indian Kala-azar before and after treatment. J. Infect. Dis. 177 (1998) 815-819
44. Santos-Gomes G.M., Rosa R., Leandro C., Cortes S., Romao P., and Silveira H. Cytokine expression during the outcome of canine experimental infection by Leishmania infantum. Vet. Immunol. Immunopathol. 88 (2002) 21-30
45. Stauber L.A. Leishmaniasis in the hamster. In: Cole W.H. (Ed). Some Physiological Aspects and Consequence of Parasitism (1955), Rugers University Press, New Brunswick 77-90
46. Tesh R.B. Control of zoonotic visceral leishmaniasis: is it time to change strategies?. Am. J. Trop. Med. Hyg. 52 (1995) 287-292
47. Titus R.G., Sherry B., and Cerami A. Tumor necrosis factor plays a protective role in experimental murine cutaneous leishmaniasis. J. Exp. Med. 170 (1989) 2097-2104
48. Viana da Costa A., Huerre M., Delacre M., Auriault C., Correia Costa J.M., and Verwaerde C. IL-10 leads to a higher parasite persistence in a resistant mouse model of Leishmania major infection. Parasitol. Int. 51 (2002) 367-379
49. Wilson M.E., Young M.B., Davidson B.L., Mente K.A., and Mcgowan S.E. The importance of TGF-β in murine visceral leishmaniasis. J. Immunol. 161 (1998) 6148-6155